The disulfide isoform of HMGB1, which seems to be the form most likely to promote seizure generation, is a potentially novel prognostic, diagnostic, and predictive biomarker of drug-resistant epilepsy in humans and highlights potential new targets for drug development (28). This evidence concerns the gene HMGB1 and epilepsy.